Health & Consumer Voice - October - 2011 Edition
The European Medicines Agency (EMA) published a new strategy for 2011-2015 aimed at combating the threat of antimicrobial resistance (AMR). This resistance may arise from antimicrobial use in animals.
Antimicrobials – including antibiotics, antivirals, antifungals and antiparasitics – are used to control infectious diseases in humans and animals, with many of the same medicines used for both. Over time, the bacteria they are used to treat become resistant to the medicine resulting in a progressive loss of effectiveness. This is referred to as antimicrobial resistance. In the EU alone, the additional burden posed by AMR every year is in the range of 2.5 million hospital days and 25 000 deaths.
To read the strategy, visit the EMA website: